Keybanc Reiterates Overweight Rating on Elanco Animal Health Incorporated (ELAN)

Market Context

Elanco Animal Health Incorporated operates in the Healthcare sector. The stock currently trades at $24.36 with a market capitalization of $10.6B. The stock has gained 88.0% over the past 52 weeks.

Analyst coverage from Keybanc provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Elanco Animal Health Incorporated.

Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.

Recent Analyst Activity for Elanco Animal Health Incorporated

Among the 10 most recent ratings: 8 Buy, 2 Hold, 0 Sell.

Date	Firm	Rating	Price Target
Aug 06, 2026	Keybanc	Overweight	N/A
Jul 22, 2026	Morgan Stanley	Equal-Weight	N/A
Jun 18, 2026	TD Cowen	Buy	N/A
May 07, 2026	Citigroup	Buy	N/A
May 07, 2026	JP Morgan	Overweight	N/A

Related Tools: Analyst Ratings Dashboard | View ELAN Stock Page